Head-To-Head Contrast: Leafly (NASDAQ:LFLYW) & PetMed Express (NASDAQ:PETS)

Leafly (NASDAQ:LFLYW) and PetMed Express (NASDAQ:PETS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

Institutional & Insider Ownership

73.3% of PetMed Express shares are held by institutional investors. 3.6% of PetMed Express shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings and price targets for Leafly and PetMed Express, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Leafly	0	0	0	0	N/A
PetMed Express	1	0	1	0	2.00

PetMed Express has a consensus price target of $13.25, indicating a potential upside of 227.16%. Given PetMed Express’ higher probable upside, analysts plainly believe PetMed Express is more favorable than Leafly.

Valuation and Earnings

This table compares Leafly and PetMed Express’ revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Leafly	$42.25 million	N/A	N/A	N/A	N/A
PetMed Express	$256.86 million	0.33	$5.14 million	($0.39)	-10.38

PetMed Express has higher revenue and earnings than Leafly.

Profitability

This table compares Leafly and PetMed Express’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Leafly	N/A	N/A	N/A
PetMed Express	-2.92%	-1.25%	-0.75%

Summary

PetMed Express beats Leafly on 5 of the 8 factors compared between the two stocks.

About Leafly

Leafly Holdings, Inc. owns and operates a platform to provide consumers with cannabis information and connects consumers to cannabis brands and licensed retailers. The company offers subscription-based marketplace listings, digital advertising solutions, and software as a service-based tools to cannabis retailers and brands; and information, reviews, menus, and ordering and delivery options to its audience through its website and mobile applications. Leafly Holdings, Inc. was founded in 2010 and is headquartered in Seattle, Washington.

About PetMed Express

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.